Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143) ; volume:7 ; number:1 ; day:4 ; month:8 ; year:2017 ; pages:1-13 ; date:12.2017
Scientific reports ; 7, Heft 1 (4.8.2017), 1-13, 12.2017
- Urheber
-
Zhang, Yanyan
Saavedra, Erika
Tang, Ruoping
Gu, Yin
Lappin, Patrick
Trajkovic, Dusko
Liu, Shu-Hui
Smeal, Tod
Fantin, Valeria
Botton, Stephane De
Legrand, Ollivier
Delhommeau, Francois
Pernasetti, Flavia
Louache, Fawzia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-07848-8
- URN
-
urn:nbn:de:101:1-2019070721591865838845
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Yanyan
- Saavedra, Erika
- Tang, Ruoping
- Gu, Yin
- Lappin, Patrick
- Trajkovic, Dusko
- Liu, Shu-Hui
- Smeal, Tod
- Fantin, Valeria
- Botton, Stephane De
- Legrand, Ollivier
- Delhommeau, Francois
- Pernasetti, Flavia
- Louache, Fawzia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
Discovery and characterization of an endogenous CXCR4 antagonist
CCR5 and CXCR4 antagonist and agonist binding sites
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924
Influence of CXCR4 on myeloid immune response after stroke
Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer
Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations
Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
Discovery and characterization of an endogenous CXCR4 antagonist
CCR5 and CXCR4 antagonist and agonist binding sites
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924
Influence of CXCR4 on myeloid immune response after stroke
Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer
Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations
Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
Discovery and characterization of an endogenous CXCR4 antagonist
CCR5 and CXCR4 antagonist and agonist binding sites
Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in waldenström’s macroglobulinemia
Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924
Influence of CXCR4 on myeloid immune response after stroke
Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer
Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations
Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Establishment of an ELISA to detect the CXCR4 antagonist hSA (408-423) and characterization of CXCR4 mutants associedet with WHIM syndrome